Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality.

Authors:
Leatherdale A; Stukas S; Lei V; West HE; Campbell CJ and 6 more

Journal:
Med Microbiol Immunol

Publication Year: 2022

DOI:
10.1007/s00430-021-00725-2

PMCID:
PMC8761108

PMID:
35034207

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Med Microbiol Immunol

Abbreviation: Med Microbiol Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Inflammation, the kynurenines, and mucosal injury during human experimental enterotoxigenic Escheri…
Rim S; Vedøy OB; Brønstad I and 4 more (2024) - Transparency Score: 5/6
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants.
Haycroft ER; Davis SK; Ramanathan P and 15 more (2023) - Transparency Score: 3/6
Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of c…
Osterman A; Krenn F; Iglhaut M and 19 more (2023) - Transparency Score: 3/6
Phenotypic and genotypic identification of carbapenem resistance in Bacteroides fragilis clinical s…
Kierzkowska M; Majewska A; Karłowicz K and 1 more (2023) - Transparency Score: 3/6
Ten rapid antigen tests for SARS-CoV-2 widely differ in their ability to detect Omicron-BA.4 and -B…
Krenn F; Dächert C; Badell I and 17 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestThe authors have no conflicts of interest to disclose. Conflict of interest The authors have no conflicts of interest to disclose."

Evidence found in paper:

"Funding EMC was supported by grants from CanVECTOR (COVID-19 Rapid Response Funding Competition), the Canada Research Chairs program, the Canadian Institutes of Health Research (#407306), and Fastgrants.org. EMC and ELGP also received support from the Heart and Stroke Foundation of Canada (EMC—G-18-0022122; ELGP—G-19-0026524). AL and HW were supported by Mitacs Accelerate Fellowships (IT19262, awarded to EMC and ELGP)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025